Journal article
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. Reply.
Bruce E Sands, Colleen Marano
N Engl J Med | Massachusetts Medical Society | Published : 2020
DOI: 10.1056/NEJMc1915042
Abstract
To the Editor: Sands et al. (Sept. 26 issue)1 have reported the results from the UNIFI trial, a double-blind, placebo-controlled trial of ustekinumab as induction and maintenance therapy for ulcera...